SEC Company Response from KIORA PHARMACEUTICALS INC (KPRX) (CIK 0001372514) (KPRX) — Oct 2, 2014
KIORA PHARMACEUTICALS INC (KPRX) (CIK 0001372514)
Date: Oct. 2, 2014 · CIK: 0001372514 · Accession: 0001144204-14-059355
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-197725
Referenced dates: September 30, 2014
Letter
Eyegate Pharmaceuticals, Inc.
Waverley Oaks Road
Suite 108
Waltham, MA 02452
October 2, 2014
United States Securities and Exchange Commission
Divison of Corporate Finance
Washington, DC 20549
Re: Eyegate Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-197725
Request for Acceleration
Ladies and Gentlemen:
Reference is made to our letter dated September 30, 2014 in which we requested the acceleration of the effective date of the above-referenced Registration Statement, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
Eyegate Pharmaceuticals, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Eyegate
Pharmaceuticals, Inc.
271
Waverley Oaks Road
Suite 108
Waltham, MA 02452
October 2, 2014
United States Securities and Exchange Commission
Divison of Corporate Finance
Washington, DC 20549
Re:
Eyegate Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-197725
Request for Acceleration
Ladies and Gentlemen:
Reference is made to our letter dated September 30, 2014 in
which we requested the acceleration of the effective date of the above-referenced Registration Statement, in accordance with Rule
461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective
at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
Eyegate Pharmaceuticals, Inc.
By:
/s/ Stephen From
Name:
Title:
Stephen From
President and Chief Executive Officer